Journal of Applied Physiology, Vol 54, Issue 2 371-374, Copyright © 1983 by American Physiological Society

ARTICLES

Lung vessel leak precedes right ventricular hypertrophy in monocrotaline-treated rats

T. Sugita, T. M. Hyers, I. M. Dauber, W. W. Wagner, I. F. McMurtry and J. T. Reeves

Monocrotaline induces microvascular leak and pulmonary hypertension in rats. We have hypothesized that the leak is related in some way to the pulmonary hypertension and precedes it. In rats given 40 mg monocrotaline/kg body wt subcutaneously, lung wet weight-to-dry weight ratios and lung albumin content began to increase within the first 3 days and became maximal at 1 wk. Alveolar lavage fluid showed little or no increase in protein. Right ventricular hypertrophy increased progressively from 2 through 3 wk. An increase in lung dry weight paralleled the right ventricular hypertrophy. The amount of blood retained in the lung did not account for the increased lung water, albumin, or weight. We considered that microvascular leak without leak into the alveolar space preceded pulmonary hypertension, right ventricular hypertrophy, and increased lung dry weight. In rats not given monocrotaline but exposed for 3 wk to hypobaric hypoxia, lung albumin, lung dry weight, and right ventricular weight increased. Increased lung dry weight probably reflects hyperplasia of lung cells. If so, an association of microvascular leak, lung cell hyperplasia, and right ventricular hypertrophy may occur in both monocrotaline- and hypoxia-induced pulmonary hypertension.

This article has been cited by other articles:

				H. Sawada, Y. Mitani, J. Maruyama, B. H. Jiang, Y. Ikeyama, F. A. Dida, H. Yamamoto, K. Imanaka-Yoshida, H. Shimpo, A. Mizoguchi, et al. A Nuclear Factor-{kappa}B Inhibitor Pyrrolidine Dithiocarbamate Ameliorates Pulmonary Hypertension in Rats Chest, October 1, 2007; 132(4): 1265 - 1274. [Abstract] [Full Text] [PDF]

				J. Lu, H. Shimpo, A. Shimamoto, A. J. Chong, C. R. Hampton, D. J. Spring, M. Yada, M. Takao, K. Onoda, I. Yada, et al. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats J. Thorac. Cardiovasc. Surg., December 1, 2004; 128(6): 850 - 859. [Abstract] [Full Text] [PDF]

				T. Itoh, N. Nagaya, S. Murakami, T. Fujii, T. Iwase, H. Ishibashi-Ueda, C. Yutani, M. Yamagishi, H. Kimura, and K. Kangawa C-type Natriuretic Peptide Ameliorates Monocrotaline-induced Pulmonary Hypertension in Rats Am. J. Respir. Crit. Care Med., December 1, 2004; 170(11): 1204 - 1211. [Abstract] [Full Text] [PDF]

				Y. Ikeda, Y. Yonemitsu, C. Kataoka, S. Kitamoto, T. Yamaoka, K.-I. Nishida, A. Takeshita, K. Egashira, and K. Sueishi Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H2021 - H2028. [Abstract] [Full Text] [PDF]

				V. Hampl and J. Herget Role of Nitric Oxide in the Pathogenesis of Chronic Pulmonary Hypertension Physiol Rev, October 1, 2000; 80(4): 1337 - 1372. [Abstract] [Full Text] [PDF]

				H. C. Thomas, M. W. Lamé, D. Morin, D. W. Wilson, and H. J. Segall Prolonged Cell-cycle Arrest Associated with Altered cdc2 Kinase in Monocrotaline Pyrrole-treated Pulmonary Artery Endothelial Cells Am. J. Respir. Cell Mol. Biol., July 1, 1998; 19(1): 129 - 142. [Abstract] [Full Text]

				R. Mathew, E. S. Gloster, T. Sundararajan, C. I. Thompson, G. A. Zeballos, and M. H. Gewitz Role of inhibition of nitric oxide production in monocrotaline-induced pulmonary hypertension J Appl Physiol, May 1, 1997; 82(5): 1493 - 1498. [Abstract] [Full Text] [PDF]

				M. Okada, C. Yamashita, M. Okada, and K. Okada Role of Endothelin-1 in Beagles With Dehydromonocrotaline-Induced Pulmonary Hypertension Circulation, July 1, 1995; 92(1): 114 - 119. [Abstract] [Full Text]